FYERS
Home
/
Stocks
/
Results
/
Bacil Pharma Results

Bacil Pharma Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---0%
---784%
--25%-58%
-79%-127%-9%3%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
CIPLA-A
LAURUSLABS-A
LUPIN-A
MANKIND-A
DRREDDY-A
AUROPHARMA-A
BACPHAR-X
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,901.5₹456833 Cr37.7712.0762.82₹11479 Cr
9,186.2₹245426 Cr83.9134.04128.41₹2568 Cr
4,858.35₹187320 Cr85.8916.7297.06₹2163 Cr
1,131.45₹113217 Cr25.099.4262.53₹5040 Cr
1,380₹112212 Cr33.299.7757.87₹3879 Cr
1,852.7₹101155 Cr92.526.829.25₹889 Cr
2,123₹97626 Cr17.6630.95154.36₹5333 Cr
2,336₹96859 Cr47.4213.7571.08₹1913 Cr
1,161.75₹96406 Cr29.925.3263.99₹4196 Cr
1,657.05₹93614 Cr25.2217.9596.84₹3505 Cr
15.3₹21 Cr31.8-0.010.46₹2 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹52 L₹0₹0
₹9 L₹11 L₹6 L₹6 L₹1 Cr₹66 L₹30,000₹56 L₹1 L₹2 L₹3 L₹3 L₹5 L₹90,000₹20,000₹4 L₹7 L₹80,000₹2 L₹2 L₹60,000₹2 L₹4 L₹2 L₹2 L₹2 L₹2 L₹9 L₹2 L₹5 L₹2 L₹2 L₹2 L₹2 L₹5 L₹3 L₹18 L₹11 L₹2 L₹3 L₹1 L₹3 L₹50,000₹2 L₹1 L₹3 L₹2 L₹2 L₹1 L₹2 L₹90,000₹2 L₹2 L₹70,000₹50,000₹0
₹9 L₹11 L₹6 L₹6 L₹1 Cr₹66 L₹30,000₹56 L₹1 L₹2 L₹3 L₹3 L₹5 L₹90,000₹20,000₹4 L₹7 L₹80,000₹2 L₹2 L₹60,000₹2 L₹4 L₹2 L₹2 L₹2 L₹2 L₹9 L₹2 L₹5 L₹2 L₹2 L₹2 L₹2 L₹5 L₹3 L₹18 L₹11 L₹2 L₹3 L₹1 L₹3 L₹50,000₹2 L₹1 L₹3 L₹2 L₹2 L₹1 L₹2 L₹90,000₹2 L₹2 L₹53 L₹50,000₹0
₹2 L₹8 L₹3 L₹4 L₹11 L₹25 L₹7 L₹7 L₹4 L₹6 L₹6 L₹4 L₹3 L₹9 L₹5 L₹4 L₹4 L₹4 Cr₹4 L₹9 L₹3 L₹21 L₹7 L₹3 L₹2 L₹4 L₹27 L₹8 L₹7 L₹10 L₹11 L₹12 L₹12 L₹12 L₹8 L₹9 L₹5 L₹7 L₹3 L₹2 L₹6 L₹3 L₹3 L₹3 L₹4 L₹3 L₹2 L₹3 L₹3 L₹10 L₹2 L₹3 L₹2 L₹59 L₹4 L₹4 L
₹7 L₹4 L₹4 L₹2 L₹89 L₹41 L-₹6 L₹49 L-₹3 L-₹4 L-₹2 L-₹1 L₹2 L-₹8 L-₹4 L-₹30,000₹2 L-₹4 Cr-₹2 L-₹8 L-₹2 L-₹19 L-₹3 L-₹60,000-₹40,000-₹2 L-₹25 L₹1 L-₹5 L-₹5 L-₹9 L-₹10 L-₹9 L-₹10 L-₹3 L-₹6 L₹13 L₹4 L-₹50,000₹80,000-₹4 L₹40,000-₹3 L-₹2 L-₹3 L-₹50,000-₹20,000-₹40,000-₹2 L-₹8 L-₹1 L-₹60,000-₹50,000-₹6 L-₹4 L-₹4 L
₹7 L₹4 L₹4 L₹2 L₹89 L₹41 L-₹6 L₹49 L-₹3 L-₹4 L-₹2 L-₹1 L₹2 L-₹8 L-₹5 L-₹40,000₹2 L-₹4 Cr-₹2 L-₹8 L-₹3 L-₹19 L-₹3 L-₹70,000-₹50,000-₹2 L-₹25 L₹1 L-₹6 L-₹5 L-₹9 L-₹10 L-₹9 L-₹4 Cr-₹3 L-₹6 L₹13 L₹4 L-₹60,000₹80,000-₹5 L₹40,000-₹3 L-₹2 L-₹3 L-₹50,000-₹40,000-₹50,000-₹2 L-₹8 L-₹1 L-₹90,000-₹50,000-₹6 L-₹4 L-₹4 L
-₹2 L₹62 L₹4 L₹1 L₹67 L₹40 L-₹6 L₹49 L-₹3 L-₹4 L-₹2 L-₹1 L₹2 L-₹8 L-₹5 L-₹40,000₹2 L-₹4 Cr-₹2 L-₹8 L-₹3 L-₹19 L-₹3 L-₹70,000-₹50,000-₹2 L-₹25 L₹1 L-₹6 L-₹5 L-₹9 L-₹10 L-₹9 L-₹4 Cr-₹3 L-₹6 L₹13 L₹4 L-₹60,000₹80,000-₹5 L₹40,000-₹3 L-₹2 L-₹3 L-₹50,000-₹40,000-₹50,000-₹2 L-₹8 L-₹1 L-₹90,000-₹50,000-₹6 L-₹4 L-₹4 L

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Unsecured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
———————————————————
₹14 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr
₹11 Cr-₹5 Cr-₹5 Cr-₹5 Cr-₹5 Cr-₹5 Cr-₹5 Cr-₹4 Cr-₹9 L-₹13 L-₹6 L-₹3 L₹8 L₹10 L₹6 L₹6 L₹9 L₹12 L₹12 L
₹11 Cr-₹5 Cr-₹5 Cr-₹5 Cr-₹5 Cr-₹5 Cr-₹5 Cr-₹4 Cr-₹9 L-₹13 L-₹6 L-₹3 L₹8 L₹10 L₹6 L₹6 L₹9 L₹12 L₹12 L
₹25 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹3 L₹3 L₹9 L₹8 L
-₹5 L-₹6 L-₹12 L-₹11 L-₹11 L-₹20 L-₹12 L-₹10 L₹2 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
-₹5 L-₹6 L-₹12 L-₹11 L-₹11 L-₹20 L-₹12 L-₹10 L₹2 L₹0₹0₹0₹0₹0₹0₹3 L₹3 L₹9 L₹8 L
———————————————————
₹41,000₹36,000₹4,000₹1 L₹1 L₹4 L₹4 L₹42,284₹36,650₹35,000₹70,000₹0₹0₹0₹0₹0₹2 L₹26 L₹14 L
₹9,000₹24,000₹10,000₹15,477₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3,708₹1 L₹41,107₹42,720₹32 L₹3 L₹6 L₹6 L₹10 L₹11 L₹15 L
₹16 L₹10 L₹2 L₹3 L₹18 L₹17 L₹10 L₹0₹31 L₹27 L₹14 L₹8 L₹0₹35 L₹8 L₹0₹0₹0₹0
₹0₹85,000₹59,000₹17,700₹90,747₹1 L₹1 L₹92,000₹52,000₹86,500₹53,370₹50,061₹76,503₹1 L₹1 L₹0₹0₹0₹0
₹17 L₹11 L₹3 L₹5 L₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹32 L₹30 L₹16 L₹9 L₹33 L₹40 L₹15 L₹6 L₹12 L₹37 L₹29 L
₹26 Cr₹1 Cr₹1 Cr₹1 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr
₹16 L₹10 L₹2 L₹3 L₹18 L₹17 L₹10 L₹0₹31 L₹27 L₹14 L₹8 L₹0₹35 L₹8 L₹3 L₹3 L₹9 L₹8 L
———————————————————
₹6 L₹6 L₹6 L₹6 L₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹6 Cr₹5 Cr₹1 L₹2 L₹1 L₹0₹6 Cr₹5 L₹5 L₹5 L₹5 L
₹6 L₹5 L₹5 L₹5 L₹4 L₹4 L₹3 L₹2 L₹1 L₹85,063₹77,223₹63,720₹7,426₹0₹0₹5 L₹5 L₹5 L₹5 L
₹0₹62,000₹82,000₹1 L₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹6 Cr₹5 Cr₹51,675₹90,180₹1 L₹0₹6 Cr₹32,383₹40,111₹49,908₹56,855
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹0₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹21 Cr₹61 L₹24 L₹24 L₹24 L₹25 L₹55 L₹32 L₹45 L₹51 L₹25 L₹25 L₹33 L₹38 L₹69 L₹69 L₹69 L₹69 L₹69 L
₹21 Cr₹61 L₹24 L₹24 L₹24 L₹25 L₹55 L₹32 L₹45 L₹51 L₹25 L₹25 L₹33 L₹38 L₹69 L₹69 L₹69 L₹69 L₹69 L
₹1 Cr₹60 L₹54 L₹60 L₹93 L₹86 L₹80 L₹63 L₹22 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹23 Cr₹1 Cr₹78 L₹85 L₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹7 Cr₹7 Cr
———————————————————
₹0₹0₹19 L₹8 L₹14 L₹18 L₹41 L₹83 L₹9 L₹0₹26 L₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹39 L₹0₹0₹0₹0₹0
₹5 L₹0₹0₹0₹0₹0₹0₹1 L₹0₹36,000₹36,000₹80,592₹50,814₹19 L₹1 L₹0₹1 L₹13 L₹0
₹3 Cr₹4 L₹3 L₹23 L₹10 L₹4 L₹9 L₹27 L₹4 L₹2 L₹2 L₹9 L₹13 L₹6 L₹8 L₹6 L₹9 L₹1 L₹2 L
₹0₹0₹0₹0₹130₹0₹0₹2 L₹3 L₹60,620₹3 L₹23 L₹23 L₹23 L₹0₹0₹0₹0₹0
₹30,000₹1 L₹91,000₹95,799₹6 L₹6 L₹6 L₹3 L₹89,420₹22 L₹18 L₹20 L₹50 L₹9 L₹32 L₹31 L₹35 L₹27 L₹27 L
₹3 Cr₹5 L₹23 L₹32 L₹30 L₹29 L₹56 L₹1 Cr₹16 L₹25 L₹49 L₹52 L₹86 L₹96 L₹41 L₹37 L₹45 L₹41 L₹29 L
₹3 Cr-₹6 L₹20 L₹27 L-₹2 Cr-₹2 Cr-₹2 Cr-₹1 Cr-₹15 L-₹4 L₹33 L₹43 L₹53 L₹56 L₹26 L₹32 L₹33 L₹4 L-₹40,189
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹69 L₹0₹0₹0₹0₹0₹0₹0₹49,250₹49,250
₹26 Cr₹1 Cr₹1 Cr₹1 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr
₹19₹1₹1₹1₹1₹1₹2₹3₹10₹9₹10₹10₹10₹10₹10₹10₹10₹10₹10
₹19₹1₹1₹1₹1₹1₹2₹3₹10₹9₹10₹10₹10₹10₹10₹10₹10₹10₹10

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹41 L-₹6 L-₹10 L-₹4 Cr-₹24 L-₹32 L-₹34 L-₹4 Cr-₹20,640-₹7 L-₹3 L-₹11 L-₹2 L₹5 L-₹57,216-₹2 L-₹4 L₹13,000₹0
-₹2 L-₹3 L-₹3 L-₹5 L-₹14 L-₹13 L-₹9 L₹3 Cr₹32,347₹7,838₹38,505₹56,294-₹12,574-₹81,473₹0₹0₹49,000₹0₹0
₹2 L₹8 L-₹2 L-₹10 L-₹2 L₹7 L₹13 L₹2 Cr-₹57,639₹13 L₹29 L₹5 L₹10 L-₹32 L₹2 L-₹2 L-₹21 L-₹4 L-₹8 L
₹40 L-₹29,000-₹15 L-₹4 Cr-₹40 L-₹38 L-₹30 L₹1 Cr-₹45,932₹6 L₹26 L-₹5 L₹8 L-₹27 L₹2 L-₹4 L-₹25 L-₹4 L-₹8 L
₹40 L-₹29,000-₹15 L-₹4 Cr-₹40 L-₹38 L-₹30 L₹1 Cr-₹45,932₹6 L₹26 L-₹5 L₹8 L-₹27 L₹2 L-₹4 L-₹25 L-₹4 L-₹8 L
₹34 L₹8 L-₹12 L₹4 Cr₹53 L₹39 L₹28 L-₹1 Cr₹2 L-₹5 L-₹33 L₹3,600-₹72,607₹26 L₹0₹99,000₹38 L₹3 L-₹5 L
₹2 Cr-₹6 L₹6 L₹33 L-₹7 L-₹6 L-₹16 L₹0₹0₹0₹0₹0₹0₹0₹0₹0-₹6 L₹1 L₹14 L
₹3 Cr₹1 L-₹20 L₹13 L₹6 L-₹5 L-₹18 L₹23 L₹2 L₹76,597-₹7 L-₹5 L₹7 L-₹2 L₹2 L-₹3 L₹8 L-₹20,000₹62,000
₹4 L₹3 L₹23 L₹10 L₹4 L₹9 L₹27 L₹4 L₹2 L₹2 L₹9 L₹13 L₹6 L₹8 L₹6 L₹9 L₹1 L₹2 L₹98,000
₹3 Cr₹4 L₹3 L₹23 L₹10 L₹4 L₹9 L₹27 L₹4 L₹2 L₹2 L₹9 L₹13 L₹6 L₹8 L₹6 L₹9 L₹1 L₹2 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)15.25
Volume (₹)19,730.00
High (₹)15.30
Upper Circuit15.30
Low (₹)14.65
Lower Circuit13.86
Prev Close14.58
52W High (₹)61.80
Price15.30
52W Low (₹)10.65

Share Market Cap & Key Ratios Overview

M.Cap (₹)20.93 Cr
Div. Yield (%)0.00
PE Ratio31.80
Debt to Equity0.01
Price to Book2.28
Book Value18.60
EPS (TTM)0.46
Face Value10.00
ROE (%)3.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
BACPHAR-XNSE
LTP
1W Low
1W High
Market cap (₹)
1903.95-16.15 (-0.84%)
1900.10
1964.85
4,56,833Cr
9153.2-115.8 (-1.25%)
9051.85
9296
2,45,426Cr
4846.85-188.15 (-3.74%)
4845.90
5049
1,87,320Cr
1132.15-54.85 (-4.62%)
1126
1191.45
1,13,217Cr
1380.4-37.6 (-2.65%)
1377
1426.20
1,12,212Cr
1846.8-88.5 (-4.57%)
1812
1947.90
1,01,155Cr
2111.4-63.6 (-2.92%)
2111.40
2209
97,626Cr
2334.5-52.9 (-2.22%)
2323.15
2407.40
96,859Cr
1161.9-15.9 (-1.35%)
1155
1179.90
96,406Cr
1657.85+7.85 (0.48%)
1623.05
1706.70
93,614Cr
15.3+3.3 (27.50%)
12.25
15.30
21Cr

Bacil Pharma Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Bacil Pharma Ltd Quaterly Results Key Takeaways